Artelo Biosciences (ARTL) Return on Equity [ROE] (2015 - 2026)
Artelo Biosciences (ARTL) posted Return on Equity [ROE] of -444.48% for Q1 2026, up 119.27 percentage points from -563.75% a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Artelo Biosciences' Return on Equity [ROE] came in at -1463.47%, down 1325.09 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -1363.10 percentage points (FY2020 to FY2025).
- In prior years, Artelo Biosciences' Return on Equity [ROE] was -138.38% in FY2024 (-74.63 pp), -63.75% in FY2023 (-19.55 pp), -44.19% in FY2022 (+3.83 pp) and -48.02% in FY2021.
- The Q1 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] increased in 1 of the last five quarters, with an average year-over-year change of -127.49 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2026, with a gain of 119.27 percentage points; the weakest was Q1 2025, with a drop of 467.67 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | -216.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -216.27% |
| Mar 31, 2026 | -499.41% |
| Mar 31, 2025 | -555.09% |
| Dec 31, 2024 | -213.17% |
| Sep 30, 2024 | -133.82% |
| Jun 30, 2024 | -124.02% |
| Mar 31, 2024 | -90.21% |
| Dec 31, 2023 | -70.17% |
| Sep 30, 2023 | -60.73% |
| Jun 30, 2023 | -55.81% |
| Mar 31, 2023 | -56.30% |
| Dec 31, 2022 | -49.96% |
| Sep 30, 2022 | -42.43% |
| Jun 30, 2022 | -33.96% |
| Mar 31, 2022 | -30.01% |
| Nov 30, 2021 | -39.51% |
| Aug 31, 2021 | -57.00% |
| May 31, 2021 | -53.11% |
| Feb 28, 2021 | -47.89% |
| Nov 30, 2020 | -73.35% |
API Access
Artelo Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();